Literature DB >> 30324322

Genetic diversity and persistent colonization of Enterococcus faecalis on ocular surfaces.

Daisuke Todokoro1, Hiroshi Eguchi2, Takashi Suzuki3, Motoo Suzuki4, Haruyuki Nakayama-Imaohji4, Tomomi Kuwahara4, Takahiro Nomura5, Haruyoshi Tomita5,6, Hideo Akiyama7.   

Abstract

PURPOSE: Enterococcus faecalis causes severe acute endophthalmitis and often leads to poor visual outcomes. Conjunctival bacterial cultures occasionally grow atypical bacteria including E. faecalis, which can potentially contribute to the development of postoperative endophthalmitis. However, the characteristics of these ocular E. faecalis strains are unknown. This study is the first attempt to determine the population characteristics of E. faecalis clinical isolates from eye infections and ocular commensals. STUDY
DESIGN: Retrospective
METHODS: Twenty-eight E. faecalis ocular isolates were collected from 23 patients at 3 referring hospitals. The multilocus sequence typing (MLST) data were analyzed using the eBURST program. Phenotypes of cytolysin and gelatinase, antibiotic susceptibility, and mutations of the quinolone resistance-determining regions (QRDRs) of gyrA and parC were also examined. Pulsed-field gel electrophoresis (PFGE) was performed for strains from the same patients.
RESULTS: PFGE revealed that 3 patients retained identical strains for 10 months to 2 and a half years. MLST identified 12 sequence types (STs), which were clustered into 3 clonal complexes (CCs) and 8 singletons, with ST179 the largest. Thirteen of the 23 isolates (56.5%) belonged to CC58, CC8, or CC2, which have previously been reported to be major CCs. Six of the 23 strains (26.0%) exhibited high-level quinolone resistance derived from mutations of the QRDRs in both gyrA and parC.
CONCLUSIONS: The sequence types of E. faecalis ocular isolates were divergent, with no eye-specific lineages observed. Persistent colonization of E. faecalis on the ocular surface was demonstrated in patients with chronic ocular surface diseases.

Entities:  

Keywords:  Enterococcus faecalis; Fluoroquinolone resistance; Multilocus sequence typing (MLST); Ocular surface; ST179

Mesh:

Substances:

Year:  2018        PMID: 30324322     DOI: 10.1007/s10384-018-0630-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  20 in total

1.  Postoperative Enterococcus faecalis endophthalmitis: virulence factors leading to poor visual outcome.

Authors:  Daisuke Todokoro; Takashi Suzuki; Shinichiro Kobayakawa; Haruyoshi Tomita; Yuichi Ohashi; Hideo Akiyama
Journal:  Jpn J Ophthalmol       Date:  2017-07-13       Impact factor: 2.447

2.  Nosocomial infection caused by vancomycin-susceptible multidrug-resistant Enterococcus faecalis over a long period in a university hospital in Japan.

Authors:  Michiaki Kudo; Takahiro Nomura; Sachie Yomoda; Koichi Tanimoto; Haruyoshi Tomita
Journal:  Microbiol Immunol       Date:  2014-11       Impact factor: 1.955

3.  Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan.

Authors:  A Matsushima; S Takakura; M Yamamoto; Y Matsumura; M Shirano; M Nagao; Y Ito; Y Iinuma; T Shimizu; N Fujita; S Ichiyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-04       Impact factor: 3.267

4.  Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis.

Authors:  Yoshihiro Oyamada; Hideaki Ito; Matsuhisa Inoue; Jun-Ichi Yamagishi
Journal:  J Med Microbiol       Date:  2006-10       Impact factor: 2.472

Review 5.  Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection.

Authors:  Ama Sadaka; Marlene L Durand; Michael S Gilmore
Journal:  Prog Retin Eye Res       Date:  2012-04-11       Impact factor: 21.198

6.  Characterization of emeA, a NorA homolog and multidrug resistance efflux pump, in Enterococcus faecalis.

Authors:  B M Jonas; B E Murray; G M Weinstock
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

7.  Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study.

Authors:  Yoshitsugu Inoue; Masahiko Usui; Yuichi Ohashi; Hiroshi Shiota; Tsutomu Yamazaki
Journal:  Jpn J Ophthalmol       Date:  2008-07-27       Impact factor: 2.447

8.  Evidence of nosocomial infection in Japan caused by high-level gentamicin-resistant Enterococcus faecalis and identification of the pheromone-responsive conjugative plasmid encoding gentamicin resistance.

Authors:  X Ma; M Kudo; A Takahashi; K Tanimoto; Y Ike
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Comprehensive molecular, genomic and phenotypic analysis of a major clone of Enterococcus faecalis MLST ST40.

Authors:  Melanie Zischka; Carsten T Künne; Jochen Blom; Dominique Wobser; Türkân Sakιnç; Kerstin Schmidt-Hohagen; P Wojtek Dabrowski; Andreas Nitsche; Johannes Hübner; Torsten Hain; Trinad Chakraborty; Burkhard Linke; Alexander Goesmann; Sonja Voget; Rolf Daniel; Dietmar Schomburg; Rüdiger Hauck; Hafez M Hafez; Petra Tielen; Dieter Jahn; Margrete Solheim; Ewa Sadowy; Jesper Larsen; Lars B Jensen; Patricia Ruiz-Garbajosa; Dianelys Quiñones Pérez; Theresa Mikalsen; Jennifer Bender; Matthias Steglich; Ulrich Nübel; Wolfgang Witte; Guido Werner
Journal:  BMC Genomics       Date:  2015-03-12       Impact factor: 3.969

10.  Genetic diversity among Enterococcus faecalis.

Authors:  Shonna M McBride; Vincent A Fischetti; Donald J Leblanc; Robert C Moellering; Michael S Gilmore
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

View more
  1 in total

1.  Genomic and phenotypic diversity of Enterococcus faecalis isolated from endophthalmitis.

Authors:  Gayatri Shankar Chilambi; Hayley R Nordstrom; Daniel R Evans; Regis P Kowalski; Deepinder K Dhaliwal; Vishal Jhanji; Robert M Q Shanks; Daria Van Tyne
Journal:  PLoS One       Date:  2021-04-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.